Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Changing computing paradigms towards power efficiency.

Klavík P, Malossi AC, Bekas C, Curioni A.

Philos Trans A Math Phys Eng Sci. 2014 Jun 28;372(2018):20130278. doi: 10.1098/rsta.2013.0278.

PMID:
24842033
[PubMed]
2.

Numerical simulation of left ventricular assist device implantations: comparing the ascending and the descending aorta cannulations.

Bonnemain J, Malossi AC, Lesinigo M, Deparis S, Quarteroni A, von Segesser LK.

Med Eng Phys. 2013 Oct;35(10):1465-75. doi: 10.1016/j.medengphy.2013.03.022. Epub 2013 May 21.

PMID:
23701842
[PubMed - indexed for MEDLINE]
3.

Takotsubo syndrome in a patient treated with sunitinib for renal cancer.

Numico G, Sicuro M, Silvestris N, Mozzicafreddo A, Trogu A, Malossi A, Cristofano A, Thiebat B.

J Clin Oncol. 2012 Aug 20;30(24):e218-20. doi: 10.1200/JCO.2012.42.4911. Epub 2012 Jul 16. No abstract available.

PMID:
22802320
[PubMed - indexed for MEDLINE]
Free Article
4.

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.

Regan MM, Neven P, Giobbie-Hurder A, Goldhirsch A, Ejlertsen B, Mauriac L, Forbes JF, Smith I, Láng I, Wardley A, Rabaglio M, Price KN, Gelber RD, Coates AS, Thürlimann B; BIG 1-98 Collaborative Group; International Breast Cancer Study Group (IBCSG).

Lancet Oncol. 2011 Nov;12(12):1101-8. doi: 10.1016/S1470-2045(11)70270-4. Epub 2011 Oct 20.

PMID:
22018631
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.

Chirgwin J, Sun Z, Smith I, Price KN, Thürlimann B, Ejlertsen B, Bonnefoi H, Regan MM, Goldhirsch A, Coates AS; BIG 1-98 Collaborative and International Breast Cancer Study Groups.

Breast Cancer Res Treat. 2012 Jan;131(1):295-306. doi: 10.1007/s10549-011-1741-6. Epub 2011 Sep 4.

PMID:
21892704
[PubMed - indexed for MEDLINE]
6.

Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer.

Regan MM, Price KN, Giobbie-Hurder A, Thürlimann B, Gelber RD; International Breast Cancer Study Group and BIG 1-98 Collaborative Group.

Breast Cancer Res. 2011 May 26;13(3):209. doi: 10.1186/bcr2837. Review.

PMID:
21635709
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.

BIG 1-98 Collaborative Group, Mouridsen H, Giobbie-Hurder A, Goldhirsch A, Thürlimann B, Paridaens R, Smith I, Mauriac L, Forbes J, Price KN, Regan MM, Gelber RD, Coates AS.

N Engl J Med. 2009 Aug 20;361(8):766-76. doi: 10.1056/NEJMoa0810818.

PMID:
19692688
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer.

Giobbie-Hurder A, Price KN, Gelber RD; International Breast Cancer Study Group; BIG 1-98 Collaborative Group.

Clin Trials. 2009 Jun;6(3):272-87. doi: 10.1177/1740774509105380.

PMID:
19528136
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.

Rabaglio M, Sun Z, Price KN, Castiglione-Gertsch M, Hawle H, Thürlimann B, Mouridsen H, Campone M, Forbes JF, Paridaens RJ, Colleoni M, Pienkowski T, Nogaret JM, Láng I, Smith I, Gelber RD, Goldhirsch A, Coates AS; BIG 1-98 Collaborative and International Breast Cancer Study Groups.

Ann Oncol. 2009 Sep;20(9):1489-98. doi: 10.1093/annonc/mdp033. Epub 2009 May 27.

PMID:
19474112
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.

Viale G, Giobbie-Hurder A, Regan MM, Coates AS, Mastropasqua MG, Dell'Orto P, Maiorano E, MacGrogan G, Braye SG, Ohlschlegel C, Neven P, Orosz Z, Olszewski WP, Knox F, Thürlimann B, Price KN, Castiglione-Gertsch M, Gelber RD, Gusterson BA, Goldhirsch A; Breast International Group Trial 1-98.

J Clin Oncol. 2008 Dec 1;26(34):5569-75. doi: 10.1200/JCO.2008.17.0829. Epub 2008 Nov 3.

PMID:
18981464
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Concerted escalation of dose and dosing duration in a phase I study of the oral camptothecin gimatecan (ST1481) in patients with advanced solid tumors.

Sessa C, Cresta S, Cerny T, Baselga J, Rota Caremoli E, Malossi A, Hess D, Trigo J, Zucchetti M, D'Incalci M, Zaniboni A, Capri G, Gatti B, Carminati P, Zanna C, Marsoni S, Gianni L.

Ann Oncol. 2007 Mar;18(3):561-8. Epub 2006 Dec 5.

PMID:
17150998
[PubMed - indexed for MEDLINE]
Free Article
12.

Sentinel lymph node mapping in colorectal cancer: a feasibility study.

Evangelista W, Satolli MA, Malossi A, Mussa B, Sandrucci S.

Tumori. 2002 Jan-Feb;88(1):37-40.

PMID:
12004848
[PubMed - indexed for MEDLINE]
13.

Chemohyperthermia for advanced abdominal malignancies: a new procedure with closed abdomen and previously performed anastomosis.

Zanon C, Clara R, Bortolini M, Malossi A, Moscato R, Celoria P, de Andrea M, Rizzo M, Chiappino I, Grazia Sciuto M, Mussa A.

Int J Hyperthermia. 2001 Sep-Oct;17(5):456-64.

PMID:
11587082
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk